The British drugmaker GlaxoSmithKline will no longer pay doctors to promote its products and will stop tying compensation of sales representatives to the number of prescriptions doctors write, its chief executive said on Monday. Notably, these two are common industry practices. The announcement appears to be a first for a major drug company.